News

Recipharm announces collaboration with Oz-UK to accelerate the development...

Global contract development and manufacturing organisation (CDMO), Recipharm has announced a collaboration with Oz-UK, a Contract Research Organisation (CRO) and provider of solutions for respiratory...

The New Pharma Legislation – A Long-Term Robust Approach

It is worth noting that political decision-makers at present happen to be under pressure to swiftly accomplish the initial reading of the European Union's ambitious...

RSSL announces new state-of-the-art facility opening as part of...

RSSL, a cutting-edge food and pharmaceutical contract research organisation announced the opening of its new state-of-the-art analytical testing facility on the University of Reading Whiteknights...

Novo Nordisk invests more than 16 billion Danish kroner...

Novo Nordisk announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 20231 to expand the existing production site in...

BMS, Avidity add another $100M to cardiovascular partnership

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced a global licensing...

Almac, Queens University Launch Drug Discovery Facility in Belfast

Almac Discovery and Queen’s University Belfast reported a five-year project to develop a new Chemoproteomics Centre of Excellence for drug discovery. The multi-million-pound facility, which...

Ardena’s new Aseptic Fill-Finish Plant in Ghent receives GMP...

Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has been granted a Good Manufacturing Practice (GMP) license by...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read